Literature DB >> 19451612

Hypoglycemia associated with the use of levofloxacin.

Seth M Garber1, Melanie W Pound, Susan M Miller.   

Abstract

PURPOSE: A case of hypoglycemia associated with levofloxacin is reported.
SUMMARY: A 58-year-old Caucasian man was admitted to the hospital for a heart failure (HF) exacerbation with suspected community-acquired pneumonia (CAP). His medical history included HF (left ventricular ejection fraction, 25-35%), hypertension, and type 2 diabetes mellitus. Renal insufficiency was noted during hospitalization, with a serum creatinine concentration of 1.5 mg/dL. The patient's only home medication was a self-reported "sugar pill," later identified as glimepiride. A chest radiograph revealed consolidation in both lung bases and bilateral pleural effusions. Levofloxacin 750 mg was administered orally on hospital day 1 for the treatment of CAP and was ordered to be administered every 48 hours. On hospital day 3, glipizide 10 mg was administered with a sliding-scale regimen of regular insulin in preparation for discharge. On hospital day 4, glipizide 10 mg was given again with the second dose of levofloxacin, 65 hours after the first levofloxacin dose was administered. The patient also received furosemide 40 mg orally twice daily, lisinopril 20 mg orally daily, and metoprolol 25 mg twice daily. The patient was discharged on hospital day 4 and returned to the emergency department early the next morning with a serum glucose concentration of 20 mg/dL. An i.v. infusion of 10% dextrose injection and three ampules of 50% dextrose injection were given to correct his hypoglycemia. Further glipizide doses were not administered.
CONCLUSION: A malnourished 58-year-old man with diabetes developed hypoglycemia after receiving levofloxacin in conjunction with glipizide.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19451612     DOI: 10.2146/ajhp080105

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  4 in total

1.  Tuberculosis and Diabetes Mellitus, Tackling Dual Maladies: Comment on Bangladeshi Tuberculosis-diabetes Mellitus Guidelines.

Authors:  Jyothi Idiculla
Journal:  Indian J Endocrinol Metab       Date:  2017 Mar-Apr

Review 2.  How Safe are Fluoroquinolones for Diabetic Patients? A Systematic Review of Dysglycemic and Neuropathic Effects of Fluoroquinolones.

Authors:  Abdulrhman Althaqafi; Long Chiau Ming; Majid Ali; Yusuf Alzahrani; Zahid Hussain
Journal:  Ther Clin Risk Manag       Date:  2021-10-13       Impact factor: 2.423

3.  Risk for hypoglycemic emergency with levofloxacin use, a population-based propensity score matched nested case-control study.

Authors:  Shu-Hui Liao; Sung-Yuan Hu; Chorng-Kuang How; Vivian Chia-Rong Hsieh; Chia-Ming Chan; Chien-Shan Chiu; Ming-Shun Hsieh
Journal:  PLoS One       Date:  2022-04-04       Impact factor: 3.240

4.  Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.

Authors:  Mathieu S Bolhuis; Prashant N Panday; Arianna D Pranger; Jos G W Kosterink; Jan-Willem C Alffenaar
Journal:  Pharmaceutics       Date:  2011-11-18       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.